A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
Phase 3
Completed
- Conditions
- Schizophrenia and Schizoaffective Disorder
- Registration Number
- NCT00292409
- Brief Summary
The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- diagnosis of schizophrenia or schizoaffective disorder being treated as outpatients,no response to past antipsychotic treatment and patients who symptoms are notoptimally controlled defined as CGI- S<7
Exclusion Criteria
- pregnant or breastfeeding,patients at risk for committing suicide,diagnosis of mood disorders, delirium, dementia and other cognitive disorders,patients treatment resistant to otherantipyschotic medications and treatment with a long acting psychotic in which the last dose was within 3 months of treatment phase
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Clinical Global Impression-Improvement at endpoint
- Secondary Outcome Measures
Name Time Method Investigator's Assessment Questionnaire Patient preference of medication at endpoint Clinical Global Impression scale